11 results
8-K
EX-99.2
RLAY
Relay Therapeutics Inc
8 Aug 23
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:14pm
rates Diversity & inclusion advisory group Training and development opportunities Equitable compensation 4 clinical programs Committed to clinical
8-K
EX-99.1
RLAY
Relay Therapeutics Inc
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
Harvard Medical School. He completed his clinical training in internal medicine and cardiology at MGH and his postdoctoral research training in human
8-K
v7fm8
27 Jul 22
Departure of Directors or Certain Officers
8:01am
8-K
EX-2.1
gek7g mldih7w02dpx6
16 Apr 21
Experimental Approaches to Create Precision Medicines by Acquiring ZebiAI
6:38am
10-K
nmd0fh7qn
25 Mar 21
Annual report
4:31pm
S-1
EX-10.7
exrrfi2y5vsr3tb3f
24 Jun 20
IPO registration
5:03pm
DRS
EX-10.7
u3tu5 i1qn
22 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next